Publications
Articles Published in   Olga Roche Losada   

1.- Arconada-Luque, E, Jiménez-Suarez, J, Pascual-Serra, R, Nam-Cha, SH, Moline, T, Cimas, FJ, Fliquete, G, Ortega-Muelas, M, Roche, O , Fernández-Aroca, DM, Muñoz Velasco, R, García-Flores, N, Garnés-García, C, Sánchez-Fdez, A, Matilla-Almazán, S, Sánchez-Arévalo Lobo, VJ, Hernández-Losa, J, Belandia, B , Pandiella, A, Esparís-Ogando, A, Ramón Y Cajal, S, Del Peso, L , Sánchez-Prieto, R , Ruiz-Hidalgo, MJ. (2022). ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology. Cancers (Basel). 14(14)(PMID: 35884568) Abstract
spacer
 

2.- Ortega-Muelas, M, Roche, O , Fernández-Aroca, DM, Encinar, JA, Albandea-Rodríguez, D , Arconada-Luque, E, Pascual-Serra, R, Muñoz, I , Sánchez-Pérez, I , Belandia, B , Ruiz-Hidalgo, MJ, Sánchez-Prieto, R . (2021). ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology. J Cell Mol Med. (PMID: 34655447) Abstract
spacer
 

3.- Roche, O , Fernández-Aroca, DM, Arconada-Luque, E, García-Flores, N, Mellor, LF, Ruiz-Hidalgo, MJ, Sánchez-Prieto, R . (2020). p38β and Cancer: The Beginning of the Road. Int J Mol Sci. 21(20)(PMID: 33053909) Abstract
spacer
 

4.- Meléndez-Rodríguez, F, Urrutia, AA, Lorendeau, D, Rinaldi, G, Roche, O , Böğürcü-Seidel, N, Ortega Muelas, M, Mesa-Ciller, C, Turiel, G, Bouthelier, A, Hernansanz-Agustín, P , Elorza, A, Escasany, E, Li, QOY, Torres-Capelli, M, Tello, D, Fuertes, E, Fraga, E, Martínez-Ruiz, A, Pérez, B, Giménez-Bachs, JM, Salinas-Sánchez, AS, Acker, T, Sánchez Prieto, R , Fendt, SM, De Bock, K, Aragonés, J. (2019). HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis. Cell Rep. 26(9): 2257-2265.e4 (PMID: 30811976) Abstract
spacer
 

5.- Serrano-Oviedo, L, Ortega-Muelas, M, García-Cano, J, Valero, ML, Cimas, FJ, Pascual-Serra, R, Fernandez-Aroca, DM, Roche, O , Ruiz-Hidalgo, MJ, Belandia, B , Giménez-Bachs, JM, Salinas, AS, Sanchez-Prieto, R . (2018). Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion. PLoS ONE. 13(7): e0200878 (PMID: 30048489) Abstract
spacer
 

6.- Meléndez-Rodríguez, F, Roche, O , Sanchez-Prieto, R , Aragones, J. (2018). Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer. Front Oncol. 8: 214 (PMID: 29938199) Abstract
spacer
 

7.- Cimas, FJ, Callejas-Valera, JL, García-Olmo, DC, Hernández-Losa, J, Melgar-Rojas, P, Ruiz-Hidalgo, MJ, Pascual-Serra, R, Ortega-Muelas, M, Roche, O , Marcos, P, Garcia-Gil, E, Fernandez-Aroca, DM, Ramón Y Cajal, S, Gutkind, JS, Sanchez-Prieto, R . (2017). E1a is an exogenous in vivo tumour suppressor. Cancer Lett. 399: 74-81 (PMID: 28416454) Abstract
spacer
 

8.- Roche, O , Deguiz, ML, Tiana, M, Galiana-Ribote, C, Martinez-Alcazar, D, Rey-Serra, C, Ranz-Ribeiro, B, Casitas, R, Galera, R, Fernández-Navarro, I, Sánchez-Cuéllar, S, Bernard, V, Ancochea, J, Wasserman, WW, García-Rio, F, Jimenez, B , Del Peso, L . (2016). Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia. Nucleic Acids Res. (PMID: 27625398) Abstract
spacer
 

9.- García-Cano, J, Roche, O , Cimas, FJ, Pascual-Serra, R, Ortega-Muelas, M, Fernández-Aroca, DM, Sánchez-Prieto, R . (2016). p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story. Front Cell Dev Biol. 4: 69 (PMID: 27446920) Abstract
spacer